Diabetes tipo II. A terapia periodontal não cirúrgica pode favorecer o controle glicêmico do paciente? / Type II Diabetes. Does nonsurgical periodontal therapy improve glycemic control in patientes? / Diabetes tipo II. ¿Puede la terapia periodontal no quirúrgica mejorar el control glicémico del paciente?

Introdução:A doença periodontal corresponde àcondição que acomete os tecidos de proteção e/ou suporte do dente através de uma inflamação crônica causadapor patógenos.Estacondição pode ser modificada ou associada às doenças sistêmicas, como por exemplo, o diabetes mellitus tipo II (DM2).Objetivo:Avaliar quais os efeitos da terapia periodontal não cirúrgica sobre o controle glicêmico de pacientes diagnosticados com DM2.Metodologia:Revisão integrativa elaborada a partir de pesquisas clínicas randomizadas indexadas nas bases de dados Pubmed, Embase, Cochrane, Web of Science e BVS, na qual foram utilizados os descritores "periodontal diseases treatment", "glycemic control" e "metabolic control".Resultados:Dos trabalhos avaliados, seis foram selecionados para compor a revisão, tendo em vista os critérios de inclusão e exclusão estabelecidos. Logo, é notório que a terapia periodontal básica indica melhora no controle glicêmico dos pacientes com DM2, de acordo comanálise da HbA1c e PCR,portanto, com base nos resultados dessa pesquisa, o tratamento periodontal não cirúrgico parece contribuir para o controle metabólico. Apesar disso, alguns estudos se opõem aoresultadodo controle glicêmicodesses pacientes, reforçando a existência de variáveis que interferem nos resultados da pesquisa, como os níveis de hemoglobina, estágio da doença periodontal, amostra, dietae atividade física dos pacientes.Conclusões:O resultado deverá ser avaliado com maior cautela, tendo em vista as possibilidades de variáveis presentes nesse tipo de pesquisa. Por fim, ensaios controlados devem ser realizados para alcançar um maior esclarecimento a respeito dos efeitos da terapia periodontal não cirúrgica no controle glicêmico de pacientes com DM2 (AU).

Introduction:Periodontal disease is a condition in which protective or supportive tissues of the tooth are affected by chronic inflammation caused by pathogens. This condition may be modified or associated with systemic diseases such as type 2 diabetes mellitus (T2DM).Objective:To evaluate the effects of nonsurgical periodontal therapy on glycemic control in patients diagnosed with T2DM. Methodology:An integrative review was performed using randomized clinical trials indexed in PubMed, Embase, Cochrane, Web of Science, and BVS databases. The descriptors "periodontal disease treatment," "glycemic control," and "metabolic control" were used. Results:From the reviewed studies, six were selected for the review considering the established inclusion and exclusion criteria.Basic periodontal therapy improves glycemic control in patients with T2DM, as evidenced by analysis of glycated hemoglobin (HbA1c) and polymerase chain reaction (PCR). Therefore, based on the results of this research, nonsurgical periodontal treatment contributes to metabolic control. However, some studies contradict the effect of glycemic control in these patients, reinforcing the presence of variables that interfere with research results, such as hemoglobin levels, stage of periodontal disease, sample, dietand physical activity of patients. Conclusions:The results should be evaluated with more caution considering the potential variables present in this type of research. Finally, controlled trials should be conducted to understand better the effects of nonsurgical periodontal therapy on glycemic control in patients with T2DM (AU).

Introducción: La enfermedad periodontal es una condición en la cual los tejidos protectores o de soportedel diente se ven afectados por una inflamación crónica causada por patógenos. Esta condición puede modificarse o asociarse a enfermedades sistémicas como la diabetes mellitus tipo 2 (DM2). Objetivo: Evaluar los efectos de la terapia periodontal no quirúrgica en el control glucémico en pacientes diagnosticados con DM2. Metodología: Se realizó una revisión integradora utilizando ensayos clínicos aleatorizados indexados en las bases de datos de PubMed, Embase, Cochrane, Web of Science y BVS. Se utilizaron los descriptores "tratamiento de enfermedades periodontales", "control glucémico" y "control metabólico". Resultados: De los estudios revisados, se seleccionaron seis para la revisión, considerando los criterios de inclusión y exclusión establecidos. La terapia periodontal básica mejora el control glucémico en pacientes con DM2, como se evidencia en el análisis de la hemoglobina glicosilada (HbA1c) y la reacción en cadena de la polimerasa (PCR). Por lo tanto, basándose en los resultados de esta investigación, el tratamiento periodontal no quirúrgico contribuye al control metabólico. Sin embargo, algunos estudios contradicen el efecto del control glucémico en estos pacientes, lo que refuerza la presencia de variables que interfieren en los resultados de la investigación, como los niveles de hemoglobina, el estadio de la enfermedad periodontal, la muestra, la dieta y la actividad física de los pacientes. Conclusiones: Los resultados deben evaluarse con mayor precaución, considerando las posibles variables presentes en este tipo de investigación. Por último, se deben realizar ensayos controlados para comprender mejor los efectos de la terapia periodontal no quirúrgica en el control glucémico en pacientes con DM2 (AU).

Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis

Abstract The evidence is inconclusive regarding the effect of periodontal treatment on glycemic control and systemic inflammation in patients with type 2 diabetes (T2D) and periodontitis Objective: To evaluate the effect of scaling and root planing (SRP) on the metabolic control and systemic inflammation of patients with type 2 diabetes (T2D). Methodology: A literature search was conducted using the MEDLINE database via PubMed and the Cochrane Central Register of Controlled Trials, from their oldest records up to July 2018. Only randomized clinical trials (RCT) were considered eligible for evaluating the effect of periodontal treatment on markers of metabolic control [glycated hemoglobin (HbA1C)] and systemic inflammation [C-reactive protein (CRP)] in patients with T2D. The quality of the studies was evaluated using the Cochrane Collaboration risk assessment tool. Meta-analyses were performed for HbA1c and CRP using random effects models. The size of the overall intervention effect was estimated by calculating the weighted average of the differences in means (DM) between the groups in each study. Heterogeneity was assessed using the Q-statistic method (x2 and I²). The level of significance was established at p<0.05. Results: Nine RCT were included. SRP was effective in reducing HbA1c [DM=0.56 (0.36-0.75); p<0.01] and CRP [DM=1.89 (1.70-2.08); p<0.01]. No heterogeneity was detected (I2=0%, p>0.05). Conclusions: SRP has an impact on metabolic control and reduction of systemic inflammation of patients with T2D.

Effect of implementation intention on walking in people with diabetes: an experimental approach

ABSTRACT OBJECTIVE To evaluate the effect of implementation intentions as an intervention strategy to promote walking in adults with type 2 diabetes mellitus (T2DM). METHODS We conducted a controlled and randomized trial, with 12 months of follow-up, involving 65 people with T2DM recruited from primary health care units and allocated them in the control group (CG, n = 32) and intervention group (IG, n = 33). The IG received the implementation intention strategy to promote walking and the CG remained in follow-up for conventional treatment in primary health care. The researchers were blinded by anthropometric measurements and the filling of the instruments. RESULTS After twelve months of follow up, the IG presented a statistically significant increase in the leisure time physical activity when compared with the CG (p = 0.0413) and showed a significant decrease in waist circumference (p = 0.0061). No significant difference was observed regarding body mass index and glycated hemoglobin among groups. CONCLUSIONS Implementation intention was effective in promoting walking and improving clinical indicators in adults with T2DM.

Assessment of glycosylated hemoglobin (HbA1c) in type 2 diabetics before and after non-surgical periodontal treatment. A short-term follow-up study

Aim: To evaluate glycosylated hemoglobin (HbA1c) before and after non-surgical periodontal treatment in patients with type 2 diabetes mellitus (DM-2). Methods: Twenty subjects diagnosed with periodontitis and DM-2 were treated using an NSPT protocol. Periodontal examination and blood measurements were performed at baseline and after three months. Patients with DM-2 treated for at least a year, with at least 10 teeth and with probing depths between 4-6 mm in more than three regions were included. The variables evaluated were HbA1c in blood and periodontal measures (probing depths, insertion level, gingival bleeding on probing, dental plaque, calculus, inflammation, clinical attachment and mobility). All patients were informed of the conditions of the therapy used. Scaling and root planning (SRP) of the full mouth was performed using an ultrasonic scaler and hand instrument under local anesthesia, supragingival prophylaxis and oral hygiene instruction. Also, 0.12% chlorhexidine digluconate was formulated twice a day for two weeks. Statistical analyses were performed using StataIC 14. The values are shown as the mean, median and standard deviation (SD) or interquartile rank (IR), and p<0.05 was considered significant. Results: Twenty subjects completed the three-month follow-up and were included in the analysis. Three months after the non-surgical periodontal treatment, most periodontal parameters had a meaningful reduction (p< 0.05) and a large effect size >0.8. Clinical attachment level showed no improvement. The HbA1c values were not significantly decreased (p=0.94). Conclusions: Although non-surgical periodontal therapy eliminates local inflammation, it is insufficient to significantly reduce HbA1c levels in a short time period

Periodontitis and type 2 diabetes among women with previous gestational diabetes: epidemiological and immunological aspects in a follow-up of three years

Abstract Periodontitis can contribute to the development of insulin resistance. Gestational diabetes is a risk factor for type 2 diabetes. Therefore, periodontitis, when associated with gestational diabetes, could increase the risk for the development of type 2 diabetes after pregnancy. Objective The aim of this study was to verify the incidence on the development of type 2 diabetes in women with previous gestational diabetes with and without periodontitis after a three-year time interval. Material and Methods Initial sample of this follow-up study consisted of 90 women diagnosed with gestational diabetes who underwent periodontal examination. After three years, 49 women were subjected to new periodontal examination and biological, behavioral, and social data of interest were collected. Additionally, the quantification of the C-reactive protein in blood samples was performed. Fasting glucose and glycated hemoglobin levels were requested. Saliva samples were collected for quantification of interleukin 6 and 10, tumor necrosis factor α, matrix metalloproteinase 2 and 9. Results The incidence of type 2 diabetes mellitus was 18.4% and of periodontitis was 10.2%. There was no significant difference in the incidence of type 2 diabetes mellitus among women with and without periodontitis. It was observed impact of C-reactive protein in the development of type 2 diabetes mellitus. However, it was not observed impact of periodontitis on the development of type 2 diabetes mellitus among women with previous gestational diabetes. Conclusions It was not observed impact of periodontitis on the development of type 2 diabetes among women with previous gestational diabetes. The impact of C-reactive protein in the development of type 2 diabetes mellitus highlights the importance of an inflammatory process in the diabetes pathogenesis.

Função endotelial e tratamento periodontal não cirúrgico de pacientes diabéticos com periodontite / Endothelial function and non-surgical periodontal treatment in diabetic patients with periodontitis

O objetivo desse estudo foi investigar alterações na função endotelial, além de realizar meta-análises sobre o uso de antibióticos adjuvantes ao tratamento periodontal não cirúrgico em relação aos possíveis benefícios em termos de parâmetros clínicos periodontais e controle glicêmico nos pacientes diabéticos com periodontite. Quarenta e oito pacientes foram avaliados quanto aos parâmetros periodontais e função endotelial. Desses 48, 11 não tinham doença periodontal e não eram diabéticos (grupo A), 17 tinham periodontite crônica e não eram diabéticos (grupo B), e 20 tinham periodontite crônica e diabetes mellitus tipo 2 (grupo C). Dois revisores independentes examinaram ensaios clínicos controlados em 6 bases de dados eletrônicas, registros de ensaios clínicos, resumos de reuniões e 4 principais revistas odontológicas. A vasodilatação dependente do endotélio (fluxo de hiperemia) foi significantemente menor no grupo C quando comparado com os grupos A e B, assim como foi significantemente menor no grupo B quando comparado com o grupo A (p<0,05). As meta-análises mostraram um efeito significativo favorecendo tratamento periodontal associado a antibióticos para reduções na média de profundiade de sondagem (-0,22 mm [-0,34, -0,11]) e na média de porcentagem de sangramento a sondagem (4% [-7, -1]). Não houve efeito significativo no ganho de nível de inserção clínica e redução do índice de placa. Além disso, a associação de antibióticos e tratamento periodontal não reduziu os valores de hemoglobina glicada média (-0,11% [-0,35, 0,13]), e um intervalo de previsão estimado variando de -0,45 a 0,23. Também não houve efeito significativo favorecendo o uso adjuvante de doxiciclina sub-antimicrobiana na redução média da hemoglobina glicada (-0,19% [-1,07, 0,68]). Sendo assim, pode-se concluir que a periodontite crônica está associada a diminuição da vasodilatação dependente do endotélio do indivíduo, assim como diminui ainda mais quando associada ao diabetes mellitus. O antibiótico sistêmico adjuvante ao tratamento periodontal proporciona benefícios estatisticamente significantes em termos de reduções de média de profundidade de bolsa a sondagem e o percentual de sangramento a sondagem, porém não proporciona um benefício significativo em termos de melhoria de nível de inserção clínico, índice de placa e hemoglobina glicada.

The aim of this study was to investigate alterations in endothelial function, besides performing meta-analyzes on the use of adjuvant antibiotics to non-surgical periodontal treatment in relation to the possible benefits in terms of periodontal clinical parameters and glycemic control in diabetic patients with periodontitis. Forty-eight patients were evaluated for periodontal parameters and endothelial function. Of these, 11 h ad no periodontal disease and were not diabetic (group A), 17 had chronic periodontitis and were not diabetic (group B), and 20 had chronic periodontitis and type 2 diabetes mellitus (group C). Two independent reviewers examined controlled clinical trials in 6 electronic databases, clinical trial records, meeting summaries, and 4 major dental journals. Endothelium-dependent vasodilation (hyperemia flow) was significantly lower in group C when compared to groups A and B, as well as significantly lower in group B when compared to group A (p <0.05). The meta-analyzes showed a significant effect favoring antibiotic-associated periodontal treatment for reductions in the mean probing pocket depth (-0,22 mm [-0,34; -0,11]) and the mean percentage of bleeding probing ( 4% [-7, -1]). There was no significant effect on gain of clinical attachment level and reduction of plaque index. In addition, the association of antibiotics and periodontal treatment did not reduce mean glycated hemoglobin values (-0,11% [-0,35, 0,13]), and an estimated prediction interval ranging from -0,45 to 0,23. There was also no significant effect favoring the adjuvant use of sub-antimicrobial doxycycline in the mean reduction of glycated hemoglobin (-0,19% [-1,07, 0,68]). Thus, it may be concluded that chronic periodontitis is associated with decreased vasodilatation dependent on the endothelium of the individual, as well as decreases even more when associated with diabetes mellitus. The systemic antibiotic adjuvant to periodontal treatment provides statistically significant benefits in terms of reductions of mean probing pocket depth and % of bleeding on probing, but does not provide a significant benefit in terms of improvement of clinical attachment level, plaque index and glycated hemoglobin.

Serum leveis of inflammatory markers in type 2 diabetes patients with chronic periodontitis

Diabetes has been associated with periodontitis, but the mechanisms through which periodontal diseases affect the metabolic control remain unclear. Objective: This study aimed to evaluate serum leveis of inflammatory markers, IL-8, IL-6 and monocyte chemoattractant protein 1 (MCP-1), in type 2 diabetic patients in the presence of chronic periodontitis. Material and Methods: Forty two individuals were enrolled in this study and assigned to one of five groups: diabetes mellitus with inadequate glycemic control and periodontitis (DMI+P, n = 10), diabetes mellitus with adequate glycemic control and periodontitis (DMA+P, n = 10), diabetes mellitus without periodontitis (DM, n = 10), periodontitis without diabetes (P, n=6), and neither diabetes nor periodontitis (H, n = 6). Periodontal clinical examination included visible plaque index (PL), gingival bleeding index (GB), probing depth (PD), attachment level (AL) and bleeding on probing (BP). Glycemic control was evaluated by serum concentration of glycated hemoglobin (HbAlc). Inflammatory serum markers IL-8, IL-6 and (MCP-1) were measured by ELISA. Results: DMI+P and DMA+P groups presented higher PD (p=0.025) and AL (p=0.003) values when compared to the P group. There were no significant differences among groups for IL-6, IL-8 and MCP-1 serum levels. Conclusions: Although periodontitis was more severe in diabetic patients, the serum levels of the investigated inflammatory markers did not differ among the groups. .

A influência do tratamento periodontal no controle glicêmico em pacientes diabéticos tipo 2 não insulino-dependentes: artigo original / Influence of periodontal treatment on glycemic control in diabetic patients type 2 non-insulin dependent: original paper

O diabetes mellitus abrange um grupo de distúrbios metabólicos que levam à hiperglicemia e tem sido proposto que o tratamento periodontal em pacientes diabéticos pode contribuir para a redução dos níveis glicêmicos. O objetivo deste trabalho foi investigar os efeitos do tratamento periodontal usando-se a técnica de “desinfecção de boca total” sobre os níveis de glicose em pacientes diabéticos tipo 2 não insulino-dependentes. Um total de 20 indivíduos foram randomicamente divididos em grupo experimental e controle. Os resultados deste estudo demonstram que indivíduos com diabetes tipo 2, não insulino-dependentes, que receberam tratamento periodontal não cirúrgico, apresentaram uma redução significativa nos níveis de hemoglobina glicosilada após 3 meses de terapia, enquanto indivíduos do grupo controle não apresentaram uma redução estatisticamente significante. Os dados sugerem um possível efeito adjunto da terapia periodontal no controle glicêmico de pacientes diabéticos.

Diabetes mellitus comprises a group of metabolic disorders that lead to hyperglycemia and its main symptoms are polydipsia, polyuria, polyphagia and weight loss. Some authors suggested that periodontal treatment in diabetic patients may contribute to the reduction of blood glucose levels. The aim of this study was to investigate the effectsof periodontal treatment using “full mouth disinfection” on glucose levels in type 2 diabetic non-insulin-dependent patients. A total of 20 individuals were randomly divided into experimental and control groups. The results of this study demonstrate that individuals with type 2 diabetes, insulin-dependent, which received non-surgical periodontal treatment, showed a significant reduction in levels of glycated hemoglobin after 3 months of therapy, while the control group did not show a statistically significant reduction. Data suggest a possible effect of periodontal therapy assistant in glycemic control in diabetic patients.

Condição Periodontal e Marcadores do Controle Metabólico em Pacientes Diabéticos / Periodontal Conditions and Metabolic Control Markers in Diabetic Patients

Objetivo: Avaliar a condição periodontal dos pacientes diabéticos tipo 2, relacionando com o controle de marcadores metabólicos.Método: Para este estudo foram selecionados 92 pacientes diabéticos que recebiam tratamento em dois centros de referência em Recife, Brasil. Foram realizados exames clínicos periodontais em seis sítios de cada dente, avaliando a profundidade de sondagem, sangramento à sondagem, perda de inserção, índice de placa dentária e número de dentes presentes. A doença periodontal foi definida pela presença de mais de 4 sítios com perda de inserção ≥ 5 mm, sendo um ou mais destes sítios com profundidade de sondagem de 4 mm ou mais. Foram realizados exames hematológicos para avaliar os marcadores metabólicos (hemoglobina glicosilada, glicemia de jejum, triglicérides, colesterol total, colesterol HDL e LDL). Foi realizada análise estatística bi-variada para verificar a associação entre as variáveis em estudo.Resultados: A avaliação da condição periodontal dos pacientes avaliados mostrou que 59,8% dos pacientes diabéticos eram portadores de doença periodontal, caracterizada por periodontite. A média de idade observada foi de 54,8 anos com DP = 9,3, o sangramento gengival à sondagem e o índice de placa foram de 33,8% e 61,07%, respectivamente. A maioria dos pacientes com níveis elevados de glicemia (≥ 126 mg / dL) apresentaram doença periodontal (62,3%),o perfil lipídico dos pacientes com doença periodontal se mostrou controlado.Conclusão: Não foi observada associação entre a condição periodontal e os marcadores do controle metabólico dos pacientes diabéticos

Objective: Evaluate the periodontal condition in diabetic patients type 2, relating to markers of metabolic control.Methods: 92 diabetic patients who received treatment in two centers in Recife, Brazil, had been invited to participate in this study. It was carried through periodontal clinical examinations in six sites of each tooth, evaluating the depth probing, bleeding probing, attachment loss, dental plaque and the number of teeth present. Periodontal disease was defined as the presence of 4 + sites with attachment loss of ≥ 5 mm with one or more than these sites with depth probing of 4 + mm. Hematologic examinations were carried out to evaluate the metabolic markers (Glycosylated Hemoglobin, fasting blood glucose, triglycerides, total cholesterol, cholesterol HDL and LDL). Bi-variate analysis were used to verified the association between variables.Results: Evaluation of periodontal condition in the sample have shown 59.8% of diabetic patients had periodontal diseases, characterized as periodontitis. The average of age observed was 54.8 years with DP= 9.3, average of bleed on probing and plaque index were 33.8% and 61.07%, respectively. The majority of patients with raised glicemic levels (≥126 mg/dL) had presented DP (62,3%), in relation to the lipidic profile the patients with periodontal disease had been presented controlled. Conclusion: In the studied population there were no signs of any association between the periodontal condition and the markers of metabolic control

Avaliação do efeito do tratamento periodontal não-cirúrgico sobre parâmetros clínicos e imunológicos em pacientes portadores de Diabetes mellitus tipo 2 / Evaluation of the effect of non-surgical periodontal treatment on clinical and immunological parameters in patients with type 2 diabetes

Objetivos: dois estudos prospectivos comparativos de intervenção foram realizados para avaliar o efeito do tratamento periodontal não-cirúrgico sobre parâmetros clínicos periodontais e imunológicos do fluido sulcular gengival e do plasma sanguíneo de pacientes com periodontite crônica portadores ou não de Diabetes mellitus Tipo 2. Material e Método: Vinte e três indivíduos com Diabetes mellitus Tipo 2 com controle metabólico inadequado e periodontite crônica (grupo diabetes) e 26 indivíduos sistemicamente saudáveis com periodontite crônica (grupo controle) foram avaliados quanto a parâmetros periodontais, marcadores inflamatórios do fluido sulcular gengival (interleucinas, metaloproteinases de matriz e atividade de elastase), marcadores inflamatórios no plasma sanguíneo (interleucinas, fator de necrose tumoral alfa, proteína C-reativa e fibrinogênio) e perfil lipídico, antes e após 3 meses do tratamento periodontal. Adicionalmente foi avaliada a influência do tratamento periodontal no controle glicêmico do grupo com diabetes. Resultados: houve redução significativa de todos os marcadores inflamatórios avaliados no fluido gengival, exceto a interleucina18, após tratamento periodontal, associado a uma melhora da condição clínica periodontal em ambos os grupos. Sistemicamente, o grupo diabetes apresentou maiores níveis de proteina C reativa e triglicérides em ambos os períodos ao se comparar com o grupo controle. O tratamento periodontal foi efetivo em reduzir os níveis de TNF-_ e fibrinogênio no grupo diabetes. Houve melhora no controle glicêmico embora não significativa. Conclusão: os resultados do presente estudo sugerem que os pacientes portadores de Diabetes mellitus Tipo 2 com controle metabólico inadequado apresentam boa resposta ao tratamento periodontal não cirúrgico, com redução de marcadores inflamatórios no fluido gengival. Entretanto, após 3 meses do tratamento periodontal, a influência deste na condição inflamatória sistêmica é limitada.

Avaliação do efeito do tratamento periodontal não-cirúrgico sobre parâmetros clínicos e imunológicos em pacientes portadores de diabetes mellitus tipo 2: estudo clínico e imunológico / Evaluation of the effect of non-surgical periodontal treatment on clinical and immunological parameters in patients with type 2 diabetes

Objetivos: dois estudos prospectivos comparativos de intervenção foram realizados para avaliar o efeito do tratamento periodontal não-cirúrgico sobre parâmetros clínicos periodontais e imunológicos do fluido sulcular gengival e do plasma sanguíneo de pacientes com periodontite crônica portadores ou não de Diabetes mellitus Tipo 2. Material e Método: Vinte e três indivíduos com Diabetes mellitus Tipo 2 com controle metabólico inadequado e periodontite crônica (grupo diabetes) e 26 indivíduos sistemicamente saudáveis com periodontite crônica (grupo controle) foram avaliados quanto a parâmetros periodontais, marcadores inflamatórios do fluido sulcular gengival (interleucinas, metaloproteinases de matriz e atividade de elastase), marcadores inflamatórios no plasma sanguíneo (interleucinas, fator de necrose tumoral alfa, proteína C-reativa e fibrinogênio) e perfil lipídico, antes e após 3 meses do tratamento periodontal. Adicionalmente foi avaliada a influência do tratamento periodontal no controle glicêmico do grupo com diabetes. Resultados: houve redução significativa de todos os marcadores inflamatórios avaliados no fluido gengival, exceto a interleucina 18, após tratamento periodontal, associado a uma melhora da condição clínica periodontal em ambos os grupos. Sistemicamente, o grupo diabetes apresentou maiores níveis de proteina C reativa e triglicérides em ambos os períodos ao se comparar com o grupo controle. O tratamento periodontal foi efetivo em reduzir os níveis de TNF-_ e fibrinogênio no grupo diabetes. Houve melhora no controle glicêmico embora não significativa. Conclusão: os resultados do presente estudo sugerem que os pacientes portadores de Diabetes mellitus Tipo 2 com controle metabólico inadequado apresentam boa resposta ao tratamento periodontal nãocirúrgico, com redução de marcadores inflamatórios no fluido gengival.

Objetive: Two prospective comparative interventional studies were performed in order to evaluate the effect of non-surgical periodontal therapy on periodontal clinical and immunological parameters in gingival crevicular fluid (CGF) and plasma of patients with chronic periodontitis with or without type 2 Diabetes mellitus (T2DM). Material and Method: Twenty three individuals with inadequately controlled T2DM and chronic periodontitis (diabetes group) and 26 systemically healthy individuals with periodontitis (control group) were assessed for clinical parameters, inflammatory biomarkers in GCF (interleukins, matrix metalloproteinases and elastase activity), circulating markers of inflammation (interleukins, tumor necrosis factor alpha, C-reactive protein and fibrinogen and lipid profile before and 3 months after periodontal therapy. Additionally, the influence of periodontal treatment on glycemic control was evaluated in the diabetes group. Results: There was a significant reduction of all inflammatory biomarkers in GCF after therapy, except for interleukin 18 levels, and it was associated with improvement on periodontal status in both groups. Systemically, the diabetes group showed high levels of C-reactive protein and triglycerides compared with the control group in both periods. The periodontal therapy was effective in reducing TNF-_ circulating and fibrinogen in the diabetes group. The treatment did not change the glycemic control significantly. Conclusion: The results of the present study suggest that patients with inadequately controlled T2DM present a good response to nonsurgical periodontal treatment, with reduction of inflammatory biomarkers in GCF. However, 3 months after therapy, its influence on systemic inflammatory condition is limited.